Allianz Asset Management GmbH reduced its position in DaVita Inc. (NYSE:DVA - Free Report) by 23.5% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 408,827 shares of the company's stock after selling 125,316 shares during the period. Allianz Asset Management GmbH owned approximately 0.53% of DaVita worth $62,538,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also recently modified their holdings of DVA. United Capital Financial Advisors LLC lifted its position in DaVita by 2.6% during the fourth quarter. United Capital Financial Advisors LLC now owns 2,416 shares of the company's stock valued at $361,000 after purchasing an additional 62 shares in the last quarter. Freedom Investment Management Inc. raised its holdings in DaVita by 3.6% during the fourth quarter. Freedom Investment Management Inc. now owns 1,790 shares of the company's stock valued at $268,000 after acquiring an additional 62 shares during the period. Wealth Enhancement Advisory Services LLC raised its holdings in DaVita by 2.0% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 3,551 shares of the company's stock valued at $531,000 after acquiring an additional 69 shares during the period. UMB Bank n.a. raised its holdings in DaVita by 65.5% during the first quarter. UMB Bank n.a. now owns 192 shares of the company's stock valued at $29,000 after acquiring an additional 76 shares during the period. Finally, Exchange Traded Concepts LLC raised its holdings in DaVita by 8.9% during the first quarter. Exchange Traded Concepts LLC now owns 970 shares of the company's stock valued at $148,000 after acquiring an additional 79 shares during the period. 90.12% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
DVA has been the topic of a number of recent analyst reports. Truist Financial decreased their price target on DaVita from $170.00 to $164.00 and set a "hold" rating on the stock in a report on Monday, May 19th. Wall Street Zen raised DaVita from a "hold" rating to a "buy" rating in a report on Friday, April 25th. One analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $167.40.
View Our Latest Analysis on DVA
Insider Activity
In other news, insider James O. Hearty sold 2,351 shares of DaVita stock in a transaction dated Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total value of $352,650.00. Following the sale, the insider directly owned 26,038 shares of the company's stock, valued at approximately $3,905,700. The trade was a 8.28% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 2.00% of the company's stock.
DaVita Price Performance
Shares of DVA stock traded up $0.26 during trading hours on Friday, hitting $145.03. The stock had a trading volume of 524,535 shares, compared to its average volume of 775,886. DaVita Inc. has a one year low of $131.76 and a one year high of $179.60. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.25 and a quick ratio of 1.20. The stock's 50-day moving average price is $140.31 and its two-hundred day moving average price is $148.33. The stock has a market capitalization of $10.95 billion, a price-to-earnings ratio of 14.37, a PEG ratio of 1.00 and a beta of 1.11.
DaVita (NYSE:DVA - Get Free Report) last issued its earnings results on Monday, May 12th. The company reported $2.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.75 by $0.25. DaVita had a return on equity of 176.11% and a net margin of 6.63%. The firm had revenue of $3.22 billion for the quarter, compared to analysts' expectations of $3.22 billion. During the same period in the previous year, the firm posted $2.26 earnings per share. The business's revenue was up 5.0% compared to the same quarter last year. Equities analysts forecast that DaVita Inc. will post 10.76 EPS for the current year.
About DaVita
(
Free Report)
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Recommended Stories
Before you consider DaVita, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DaVita wasn't on the list.
While DaVita currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
